150 related articles for article (PubMed ID: 38057657)
1. Spontaneous regression of recurrent pulmonary large cell neuroendocrine carcinoma with alteration of PD-L1 expression after surgical resection: A case report.
Hong G; Chung C; Park D; Lee SI; Lee JE; Kang DH
Thorac Cancer; 2024 Jan; 15(3):266-270. PubMed ID: 38057657
[TBL] [Abstract][Full Text] [Related]
2. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment with temozolomide in an elderly woman with advanced pulmonary large-cell neuroendocrine carcinoma: A case report.
Wei J; Dong XF; Hu ZL; Tang S; Lu YF
Medicine (Baltimore); 2018 Dec; 97(51):e13318. PubMed ID: 30572435
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC).
Hermans BCM; Derks JL; Thunnissen E; van Suylen RJ; den Bakker MA; Groen HJM; Smit EF; Damhuis RA; van den Broek EC; Stallinga CM; Roemen GM; Speel EJM; Dingemans AC;
Lung Cancer; 2019 Apr; 130():179-186. PubMed ID: 30885341
[TBL] [Abstract][Full Text] [Related]
5. Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report.
Watanabe M; Matsumura Y; Yamaguchi H; Mine H; Takagi H; Ozaki Y; Fukuhara M; Muto S; Okabe N; Shio Y; Suzuki H
Thorac Cancer; 2022 Oct; 13(19):2817-2822. PubMed ID: 36064196
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Large Cell Neuroendocrine Carcinoma.
Yang L; Fan Y; Lu H
Pathol Oncol Res; 2022; 28():1610730. PubMed ID: 36304941
[TBL] [Abstract][Full Text] [Related]
7. Pathological diagnosis of pulmonary large cell neuroendocrine carcinoma by endobronchial ultrasound-guided transbronchial needle aspiration.
Inage T; Nakajima T; Fujiwara T; Sakairi Y; Wada H; Suzuki H; Iwata T; Chiyo M; Nakatani Y; Yoshino I
Thorac Cancer; 2018 Feb; 9(2):273-277. PubMed ID: 29271588
[TBL] [Abstract][Full Text] [Related]
8. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.
Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ
Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086
[TBL] [Abstract][Full Text] [Related]
9. [Metastatic carcinoma of the adrenal gland from large cell neuroendocrine carcinoma; report of a case].
Matsuoka T; Morikage N; Kuga T; Nakayama T; Fujii Y
Kyobu Geka; 2005 Jun; 58(6):499-503. PubMed ID: 15957427
[TBL] [Abstract][Full Text] [Related]
10. Long-term survivor of pulmonary combined large cell neuroendocrine carcinoma treated with nivolumab.
Oda R; Okuda K; Yamashita Y; Sakane T; Tatematsu T; Yokota K; Endo K; Nakanishi R
Thorac Cancer; 2020 Jul; 11(7):2036-2039. PubMed ID: 32379390
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous histological transformation of lung squamous-cell carcinoma to large cell neuroendocrine carcinoma and small cell lung cancer.
Li JD; Jin CY; Zhang Y; Guo H; Zhang GL; Wang CG
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11333-11337. PubMed ID: 37369800
[TBL] [Abstract][Full Text] [Related]
12. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population-based analysis.
Yang Q; Xu Z; Chen X; Zheng L; Yu Y; Zhao X; Chen M; Luo B; Wang J; Sun J
Thorac Cancer; 2019 Apr; 10(4):751-760. PubMed ID: 30734490
[TBL] [Abstract][Full Text] [Related]
14. The Role of Systemic Therapy in the Management of Stage I Large Cell Neuroendocrine Carcinoma of the Lung.
Kujtan L; Muthukumar V; Kennedy KF; Davis JR; Masood A; Subramanian J
J Thorac Oncol; 2018 May; 13(5):707-714. PubMed ID: 29391287
[TBL] [Abstract][Full Text] [Related]
15. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases.
Jiang SX; Kameya T; Shoji M; Dobashi Y; Shinada J; Yoshimura H
Am J Surg Pathol; 1998 May; 22(5):526-37. PubMed ID: 9591721
[TBL] [Abstract][Full Text] [Related]
16. Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
Kinslow CJ; May MS; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK
Clin Lung Cancer; 2020 Mar; 21(2):e99-e113. PubMed ID: 31601526
[TBL] [Abstract][Full Text] [Related]
17. Large cell neuroendocrine carcinoma of the lung with a cystic appearance on computed tomography.
Tanaka K; Tsuboi M; Kato H
Jpn J Thorac Cardiovasc Surg; 2006 Apr; 54(4):174-7. PubMed ID: 16642926
[TBL] [Abstract][Full Text] [Related]
18. Large cell neuroendocrine carcinoma of the submandibular gland: case report and literature review.
Yamamoto N; Minami S; Kidoguchi M; Shindo A; Tokumaru Y; Fujii M
Auris Nasus Larynx; 2014 Feb; 41(1):105-8. PubMed ID: 23953500
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary large-cell neuroendocrine carcinoma (LCNEC).
Hage R; Seldenrijk K; de Bruin P; van Swieten H; van den Bosch J
Eur J Cardiothorac Surg; 2003 Apr; 23(4):457-60. PubMed ID: 12694759
[TBL] [Abstract][Full Text] [Related]
20. The genomic mutational landscape and its correlation with TMB, PD-L1 expression and CD8
Li Y; Shi X; Mao B; Wang L; Wu L; Li J; Jiao S
Lung Cancer; 2022 Apr; 166():161-169. PubMed ID: 35287068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
